Diagnosing asthma in the era of personalised medicine: biology, physiology and imaging

D. Stolz (Basel, Switzerland)

Source: Virtual Congress 2021 – Precision medicine in asthma and COPD
Session: Precision medicine in asthma and COPD
Session type: Symposium
Number: 2609

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Stolz (Basel, Switzerland). Diagnosing asthma in the era of personalised medicine: biology, physiology and imaging. Virtual Congress 2021 – Precision medicine in asthma and COPD

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Predictive and personalised medicine for asthma using genomics
Source: Annual Congress 2012 - Genetics and genomics in asthma and COPD: prediction and personalised medicine
Year: 2012


From systems biology to P4 medicine: applications in respiratory medicine
Source: Eur Respir Rev, 27 (147) 170110; 10.1183/16000617.0110-2017
Year: 2018



In the era of personalized medicine, what are the current unmet needs in asthma?
Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now?
Year: 2019

The future of personalised medicine in COPD
Source: International Congress 2016 – Endotyping: the means to personalised medicine in lung disease
Year: 2016


Asthma susceptibility: from pathophysiology to personalised medicine
Source: International Congress 2015 – ME4 Asthma susceptibility
Year: 2015




Biomarkers and personalised medicine for asthma
Source: Eur Respir J, 53 (1) 1802094; 10.1183/13993003.02094-2018
Year: 2019



The microbiome in respiratory medicine: current challenges and future perspectives
Source: Eur Respir J , 49 (4)  1602086; DOI: 10.1183/13993003.02086-2016
Year: 2017



Pulmonary xenon-129 MRI: new opportunities to unravel enigmas in respiratory medicine
Source: Eur Respir J, 55 (2) 1901987; 10.1183/13993003.01987-2019
Year: 2020



The impact of personalised therapies on respiratory medicine
Source: Eur Respir Rev 2013; 22: 72-74
Year: 2013



Advances in sleep medicine
Source: Annual Congress 2011 - COPD Research Award Ceremony (supported by Boehringer Ingelheim) followed by Clinical Year in Review II
Year: 2011


Value of animal models. Lessons learnt from another therapeutic area: implications for respiratory disease
Source: Annual Congress 2007 - PG11 - Translation of animal models to human airway disease
Year: 2007



What is evidence-based medicine?
Source: Annual Congress 2006 - PG16 - The use of evidence-based medicine and practice for the clinician (jointly organised with the ACCP)
Year: 2006



Facts and perspectives in the development of new diagnostics
Source: Annual Congress 2008 - New insights into tuberculosis control
Year: 2008


Applications of evolving technologies in sleep medicine
Source: Breathe 2013; 9: 442-455
Year: 2013

Tomorrow’s medicine today: overview of personalised medicine and insights into tomorrow’s world
Source: International Congress 2016 – Primary Care Day: challenging times III
Year: 2016